26 April 2025 in Nature Communications
Clinical pathogen diagnostics detect targets by qPCR (but with low sensitivity) or blood culturing (but time-consuming). Here we leverage a dual-stem-loop DNA amplifier to enhance non-specific collateral enzymatic cleavage of an oligonucleotide linker between a fluophore and its quencher by CRISPR-CasΦ, achieving ultrasensitive target detection. Specifically, the target pathogens are lysed to release DNA, which binds its complementary gRNA in CRISPR-CasΦ to activate the collateral DNA-cleavage capability of CasΦ, enabling CasΦ to cleave the stem-loops in the amplifier. The cleavage product binds its complementary gRNA in another CRISPR-CasΦ to activate more CasΦ. The activated CasΦ collaterally cleaves the linker, releasing the fluophore to recover its fluorescent signal. The cycle of stem-loop-cleavage/CasΦ-activation/fluorescence-recovery amplifies the detection signal. Our target amplification-free collateral-cleavage-enhancing CRISPR-CasΦ method (TCC), with a detection limit of 0.11 copies/μL, demonstrates enhanced sensitivity compared to qPCR. It can detect pathogenic bacteria as low as 1.2 CFU/mL in serum within 40 min.
22 November 2023 in Talanta
12 February 2026 in Nature Communications
Accurate single-nucleotide discrimination of miRNA is clinically vital because small sequence variations can have significant phenotypic and clinical consequences, yet existing techniques can only detect single nucleotide variations (SNVs) at specific loci. Here, we present a generalized peptide nucleic acid ( P NA) mediated C RI SPR/ C as13a syst e m (PRICE), enabling detection of SNVs in miRNA sequence without sacrificing the sensitivity. PRICE utilizes PNA blockers fully complementary to non-target miRNAs (e.g., miRNAs containing SNVs at loci of no interest) but not to the target miRNA. These blockers selectively hybridize with and inhibit non-target sequences in samples (serum, cells, or tissues). Only the unhybridized target miRNA then binds to crRNA within the Cas13a complex, activating Cas13a to cleave a fluorescent reporter-quencher linker, generating a detectable signal (~10 fM limit). By designing a panel of PNAs against SNVs, PRICE provides a versatile, amplification-free platform for precise miRNA analysis, advancing cancer diagnosis, prognosis, and biology.
2 June 2023 in Analytica Chimica Acta
4 January 2025 in The Analyst
ASAbdushkur A. Sarimsakov
+13
The study of microbial growth curves is essential for comprehending microbial behavior and enhancing related processes. Current monitoring methods face limitations, including low automation, inefficient detection, and insufficient throughput. To address these challenges, we developed the Real-Time Microbial Growth Curve (RMGC) system, which offers fully automated and high-throughput monitoring of microbial growth through an Improved Microplate Reader (IMR) with a user-friendly graphical interface. By optimizing and calibrating the optical pathways, we achieve high-precision and consistent absorbance detection using LED light sources, surpassing traditional xenon lamp microplate readers, which lack continuous operation capabilities. We validated the RMGC system by cultivating 96 samples of Escherichia coli (E. coli) at a concentration of 105 CFU mL−1. After approximately 12 hours of continuous monitoring, the system exhibited a relative standard deviation (RSD) of less than 3.25% for optical density (OD) measurements and an RSD of 2.52% for the point of inflection (POI). These results indicate a similar level of precision but a longer monitoring time compared to conventional microplate readers, reflecting the effectiveness of the RMGC system in accurately monitoring microbial growth. The RMGC system showcases its versatility through various applications, such as microorganism gradient cultures, anaerobic microbial cultures, and antimicrobial susceptibility testing (AST). Its capabilities have important implications for multiple industries, including pharmaceuticals for antibiotic development, food safety for microbial contamination testing, and microbiological research.
19 November 2025 in Cell Systems